Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. Schrag SJ, et al. Among authors: cieslak pr. N Engl J Med. 2000 Jan 6;342(1):15-20. doi: 10.1056/NEJM200001063420103. N Engl J Med. 2000. PMID: 10620644 Free article.
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Lefkowitz L, Cieslak PR, Cetron M, Zell ER, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Whitney CG, et al. Among authors: cieslak pr. N Engl J Med. 2000 Dec 28;343(26):1917-24. doi: 10.1056/NEJM200012283432603. N Engl J Med. 2000. PMID: 11136262 Free article.
Macrolide resistance among invasive Streptococcus pneumoniae isolates.
Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S, Barrett NL, Schaffner W, Cieslak PR, Maupin PS, Zell ER, Jorgensen JH, Facklam RR, Whitney CG; Active Bacterial Core Surveillance/Emerging Infections Program Network. Hyde TB, et al. Among authors: cieslak pr. JAMA. 2001 Oct 17;286(15):1857-62. doi: 10.1001/jama.286.15.1857. JAMA. 2001. PMID: 11597287
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Whitney CG, et al. N Engl J Med. 2003 May 1;348(18):1737-46. doi: 10.1056/NEJMoa022823. N Engl J Med. 2003. PMID: 12724479 Free article.
Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999.
Kennedy M, Villar R, Vugia DJ, Rabatsky-Ehr T, Farley MM, Pass M, Smith K, Smith P, Cieslak PR, Imhoff B, Griffin PM; Emerging Infections Program FoodNet Working Group. Kennedy M, et al. Among authors: cieslak pr. Clin Infect Dis. 2004 Apr 15;38 Suppl 3:S142-8. doi: 10.1086/381580. Clin Infect Dis. 2004. PMID: 15095183
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.
O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C; Active Bacterial Core Surveillance Team. O'Loughlin RE, et al. Clin Infect Dis. 2007 Oct 1;45(7):853-62. doi: 10.1086/521264. Epub 2007 Aug 29. Clin Infect Dis. 2007. PMID: 17806049
144 results